These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35398514)

  • 1. Structural brain characteristics and gene co-expression analysis: A study with outcome label from normal cognition to mild cognitive impairment.
    Cai S; Yang F; Wang X; Wu S; ; Huang L
    Neurobiol Learn Mem; 2022 May; 191():107620. PubMed ID: 35398514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between structural brain features and gene expression by weighted gene co-expression network analysis in conversion from MCI to AD.
    Wang X; Huang K; Yang F; Chen D; Cai S; Huang L
    Behav Brain Res; 2021 Jul; 410():113330. PubMed ID: 33940051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of Multilocus Genetic Risk into the Default Mode Network Longitudinal Trajectory during the Alzheimer's Disease Process.
    Su F; Shu H; Ye Q; Xie C; Yuan B; Zhang Z; Bai F
    J Alzheimers Dis; 2017; 56(2):491-507. PubMed ID: 28035927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
    Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
    Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting perfusion deficit in Alzheimer's disease and mild cognitive impairment patients by resting-state fMRI.
    Yan S; Qi Z; An Y; Zhang M; Qian T; Lu J
    J Magn Reson Imaging; 2019 Apr; 49(4):1099-1104. PubMed ID: 30318645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer's disease with dementia.
    Siafarikas N; Alnæs D; Monereo-Sanchez J; Lund MJ; Selbaek G; Stylianou-Korsnes M; Persson K; Barca ML; Almdahl IS; Fladby T; Aarsland D; Andreassen OA; Westlye LT
    Int Psychogeriatr; 2021 Nov; 33(11):1217-1228. PubMed ID: 34399870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
    Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
    Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
    Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A
    Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
    Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
    Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations of regional homogeneity in Parkinson's disease with mild cognitive impairment: a preliminary resting-state fMRI study.
    Li MG; Liu TF; Zhang TH; Chen ZY; Nie BB; Lou X; Wang ZF; Ma L
    Neuroradiology; 2020 Mar; 62(3):327-334. PubMed ID: 31822931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical Thickness Differences Are Associated With Chemical Synaptic Transmission Upregulated Genes in Degeneration of Mild Cognitive Impairment.
    Cai S; Huang K; Yang F; Wang X; Wu S; Wang Y; Huang L
    Front Aging Neurosci; 2021; 13():745381. PubMed ID: 34776930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    Choi M; Youn H; Kim D; Lee S; Suh S; Seong JK; Jeong HG; Han CE
    PLoS One; 2019; 14(8):e0220739. PubMed ID: 31369629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic Score for Conscientiousness Is a Protective Factor for Reversion from Mild Cognitive Impairment to Normal Cognition.
    Yang X; Wang Z; Li H; Qin W; Liu N; Liu Z; Wang S; Xu J; Wang J;
    Adv Sci (Weinh); 2024 Aug; 11(29):e2309889. PubMed ID: 38838096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Connectivity in Mild Cognitive Impairment and Alzheimer Disease Revealed by Multimodal Neuroimaging Data.
    Li Q; Wu X; Xie F; Chen K; Yao L; Zhang J; Guo X; Li R;
    Neurodegener Dis; 2018; 18(1):5-18. PubMed ID: 29334684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.